Evaluation of the Blood Pressure Lowering-Effect of the Lactotripeptides Valine-Proline-Proline and Isoleucine-Proline-Proline in Non-Hypertensive Japanese Subjects through a Meta-Analysis of Randomized-Controlled Studies — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Evaluation of the Blood Pressure Lowering-Effect of the Lactotripeptides Valine-Proline-Proline and Isoleucine-Proline-Proline in Non-Hypertensive Japanese Subjects through a Meta-Analysis of Randomized-Controlled Studies
Several studies have reported the ability of the lactotripeptides valine-proline-proline (VPP) and isoleucine-proline-proline (IPP) to lower systolic blood pressure (SBP), including in Japanese populations. But the magnitude of the reported changes differs across trials. Conclusions from a previous meta-analysis in Japanese subjects suggest that this may be due at least partly to differences in subjects’ blood pressure (BP) status. Therefore, we decided to resume this analysis, focusing only on non-hypertensive subjects and including newly-published eligible studies, in order to further evaluate the SBP-lowering effect of VPP/IPP and study the influence of the ingested dose, type of ingredient (enzymatic or fermented) and food product (drink or supplement). The systematic search of four databases (including two in Japanese) allowed to identify 11 relevant randomized-controlled trials (581 subjects), which were included in the meta-analysis. Results reported a significant decrease in SBP following VPP/IPP intake in non-hypertensive Japanese individuals, with an estimated effect-size of -3.44 mm Hg (95% CI, -4.53 to -2.34, P < 0.0001) as compared to placebo. There was no indication of heterogeneity or publication bias. Furthermore, the type of food product and ingredient did not influence the SBP-lowering effect, which was significant and of same order of magnitude with either type of product and ingredient. Besides, the SBP-lowering effect remained significant when limiting to studies testing usual daily amounts of VPP/IPP (≤5 mg/d). This updated meta-analysis therefore confirms that VPP/IPP are effective in reducing SBP in non-hypertensive Japanese individuals, for amounts that may be ingested on a daily basis, and independently of the types of ingredient/food consumed. VPP/IPP-containing foods could therefore contribute to a better control of high-normal BP and/or to the maintenance of normal BP, and by such, may play a role in preventing high BP in individuals with normal or high-normal BP.
KeywordsBlood PressureIPPVPPJapaneseMeta-Analysis
Nakamura, K., Okamura, T., Miura, K. and Okayama, A. (2014) Hypertension and Medical Expenditure in the Japanese Population: Review of Prospective Studies. World Journal of Cardiology, 6, 531-538. https://doi.org/10.4330/wjc.v6.i7.531
Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Bohm, M., et al. (2013) 2013 Esh/Esc Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (Esh) and of the European Society of Cardiology (Esc). Journal of Hypertension, 31, 1281-1357. https://doi.org/10.1097/01.hjh.0000431740.32696.cc
Cicero, A.F., Gerocarni, B., Laghi, L. and Borghi, C. (2011) Blood Pressure Lowering Effect of Lactotripeptides Assumed as Functional Foods: A Meta-Analysis of Current Available Clinical Trials. Journal of Human Hypertension, 25, 425-436. https://doi.org/10.1038/jhh.2010.85
Pripp, A.H. (2008) Effect of Peptides Derived from Food Proteins on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials. Food & Nutrition Research, 52.
Xu, J.Y., Qin, L.Q., Wang, P.Y., Li, W. and Chang, C. (2008) Effect of Milk Tripeptides on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials. Nutrition, 24, 933-940. https://doi.org/10.1016/j.nut.2008.04.004
Turpeinen, A.M., Jarvenpaa, S., Kautiainen, H., Korpela, R. and Vapaatalo, H. (2013) Antihypertensive Effects of Bioactive Tripeptides-a Random Effects Meta-Analysis. Annals of Medicine, 45, 51-56. https://doi.org/10.3109/07853890.2012.663926
Qin, L.Q., Xu, J.Y., Dong, J.Y., Zhao, Y., van Bladeren, P. and Zhang, W. (2013) Lactotripeptides Intake and Blood Pressure Management: A Meta-Analysis of Randomised Controlled Clinical Trials. Nutrition, Metabolism and Cardiovascular Diseases, 23, 395-402. https://doi.org/10.1016/j.numecd.2013.02.006
Nakamura, Y., Yamamoto, N., Sakai, K., Okubo, A., Yamazaki, S. and Takano, T. (1995a) Purification and Characterization of Angiotensin I-Converting Enzyme Inhibitors from Sour Milk. Journal of Dairy Science, 78, 777-783. https://doi.org/10.3168/jds.S0022-0302(95)76689-9
Nakamura, Y., Yamamoto, N., Sakai, K. and Takano, T. (1995b) Antihypertensive Effect of Sour Milk and Peptides Isolated from It That Are Inhibitors to Angiotensin I-Converting Enzyme. Journal of Dairy Science, 78, 1253-1257. https://doi.org/10.3168/jds.S0022-0302(95)76745-5
Masuda, O., Nakamura, Y. and Takano, T. (1996) Antihypertensive Peptides Are Present in Aorta after Oral Administration of Sour Milk Containing These Peptides to Spontaneously Hypertensive Rats. The Journal of Nutrition, 126, 3063-3068. https://doi.org/10.1093/jn/126.12.3063
Sipola, M., Finckenberg, P., Korpela, R., Vapaatalo, H. and Nurminen, M.L. (2002) Effect of Long-Term Intake of Milk Products on Blood Pressure in Hypertensive Rats. Journal of Dairy Research, 69, 103-111. https://doi.org/10.1017/S002202990100526X
Sipola, M., Finckenberg, P., Santisteban, J., Korpela, R., Vapaatalo, H. and Nurminen, M.L. (2001) Long-Term Intake of Milk Peptides Attenuates Development of Hypertension in Spontaneously Hypertensive Rats. Journal of Physiology and Pharmacology, 52, 745-754.
Pina, A.S. and Roque, A.C. (2009) Studies on the Molecular Recognition between Bioactive Peptides and Angiotensin-Converting Enzyme. Journal of Molecular Recognition, 22, 162-168. https://doi.org/10.1002/jmr.905
Hirota, T., Nonaka, A., Matsushita, A., Uchida, N., Ohki, K., Asakura, M., et al. (2011) Milk Casein-Derived Tripeptides, VPP and IPP Induced No Production in Cultured Endothelial Cells and Endothelium-Dependent Relaxation of Isolated Aortic Rings. Heart Vessels, 26, 549-556. https://doi.org/10.1007/s00380-010-0096-y
Yamaguchi, N., Kawaguchi, K. and Yamamoto, N. (2009) Study of the Mechanism of Antihypertensive Peptides VPP and IPP in Spontaneously Hypertensive Rats by DNA Microarray Analysis. European Journal of Pharmacology, 620, 71-77. https://doi.org/10.1016/j.ejphar.2009.08.005
Siltari, A., Korpela, R. and Vapaatalo, H. (2016) Bradykinin-Induced Vasodilatation: Role of Age, Ace1-Inhibitory Peptide, Mas- and Bradykinin Receptors. Peptides, 85, 46-55. https://doi.org/10.1016/j.peptides.2016.09.001
Usinger, L., Ibsen, H., Linneberg, A., Azizi, M., Flambard, B. and Jensen, L.T. (2010) Human in Vivo Study of the Renin-Angiotensin-Aldosterone System and the Sympathetic Activity after 8 Weeks Daily Intake of Fermented Milk. Clinical Physiology and Functional Imaging, 30, 162-168. https://doi.org/10.1111/j.1475-097X.2009.00921.x
Miyazaki, H., Nakamura, T., Ohki, K. and Nagai, K. (2017) Effects of the Bioactive Peptides Ile-Pro-Pro and Val-Pro-Pro upon Autonomic Neurotransmission and Blood Pressure in Spontaneously Hypertensive Rats. Autonomic Neuroscience, 208, 88-92. https://doi.org/10.1016/j.autneu.2017.09.017
Fekete, A.A., Givens, D.I. and Lovegrove, J.A. (2015) Casein-Derived Lactotripeptides Reduce Systolic and Diastolic Blood Pressure in a Meta-Analysis of Randomised Clinical Trials. Nutrients, 7, 659-681. https://doi.org/10.3390/nu7010659
Cicero, A.F., Aubin, F., Azais-Braesco, V. and Borghi, C. (2013) Do the Lactotripeptides Isoleucine-Proline-Proline and Valine-Proline-Proline Reduce Systolic Blood Pressure in European Subjects? A Meta-Analysis of Randomized Controlled Trials. American Journal of Hypertension, 26, 442-449. https://doi.org/10.1093/ajh/hps044
Chanson-Rolle, A., Aubin, F., Braesco, V., Hamasaki, T. and Kitakaze, M. (2015) Influence of the Lactotripeptides Isoleucine-Proline-Proline and Valine-Proline-Proline on Systolic Blood Pressure in Japanese Subjects: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS ONE, 10, e0142235. https://doi.org/10.1371/journal.pone.0142235
van der Zander, K., Bots, M.L., Bak, A.A., Koning, M.M. and de Leeuw, P.W. (2008) Enzymatically Hydrolyzed Lactotripeptides Do Not Lower Blood Pressure in Mildly Hypertensive Subjects. The American Journal of Clinical Nutrition, 88, 1697-1702. https://doi.org/10.3945/ajcn.2008.26003
Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gotzsche, P.C., Ioannidis, J.P., et al. (2009) The Prisma Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Healthcare Interventions: Explanation and Elaboration. BMJ, 339, b2700. https://doi.org/10.1136/bmj.b2700
Dent, M.P., O’Hagan, S., Braun, W.H., Schaetti, P., Marburger, A. and Vogel, O. (2007) A 90-Day Subchronic Toxicity Study and Reproductive Toxicity Studies on Ace-Inhibiting Lactotripeptide. Food and Chemical Toxicology, 45, 1468-1477. https://doi.org/10.1016/j.fct.2007.02.006
Jadad, A.R., Moore, R.A., Carroll, D., Jenkinson, C., Reynolds, D.J.M., Gavaghan, D.J., et al. (1996) Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary? Controlled Clinical Trials, 17, 1-12. https://doi.org/10.1016/0197-2456(95)00134-4
Sutton, A.J., Abrams, K.R., Jones, D.R., Sheldon, T.A. and Song, F. (2000) Methods for Meta-Analysis in Medical Research. Wiley, Hoboken.
Viechtbauer, W. (2010) Conducting Meta-Analyses in R with the Metafor Package. Journal of Statistical Software, 36, 1-48. https://doi.org/10.18637/jss.v036.i03
Cochran, W. (1954) The Combination of Estimates from Different Experiments. Biometrics, 10, 101-129. https://doi.org/10.2307/3001666
Begg, C.B. and Mazumdar, M. (1994) Operating Characteristics of a Rank Correlation Test for Publication Bias. Biometrics, 50, 1088-1101. https://doi.org/10.2307/2533446
Aihara, K., Kajimoto, O., Hirata, H., Takahashi, R. and Nakamura, Y. (2005) Effect of Powdered Fermented Milk with Lactobacillus helveticus on Subjects with High-Normal Blood Pressure or Mild Hypertension. Journal of the American College of Nutrition, 24, 257-265. https://doi.org/10.1080/07315724.2005.10719473
Ishida, Y., Shibata, Y., Fukuhara, I., Yano, Y., Takehara, I. and Kaneko, K. (2011) Effect of an Excess Intake of Casein Hydrolysate Containing Val-Pro-Pro and Ile-Pro-Pro in Subjects with Normal Blood Pressure, High-Normal Blood Pressure, or Mild Hypertension. Bioscience, Biotechnology, and Biochemistry, 75, 427-433. https://doi.org/10.1271/bbb.100560
Mizuno, S., Matsuura, K., Gotou, T., Nishimura, S., Kajimoto, O., Yabune, M., et al. (2005) Antihypertensive Effect of Casein Hydrolysate in a Placebo-Controlled Study in Subjects with High-Normal Blood Pressure and Mild Hypertension. British Journal of Nutrition, 94, 84-91. https://doi.org/10.1079/BJN20051422
Sano, J., Ohki, K., Higuchi, T., Aihara, K., Mizuno, S., Kajimoto, O., et al. (2005) Effect of Casein Hydrolysate, Prepared with Protease Derived from Aspergillus oryzae, on Subjects with High-Normal Blood Pressure or Mild Hypertension. Journal of Medicinal Food, 8, 423-430. https://doi.org/10.1089/jmf.2005.8.423
Ishida, Y., Aihara, K., Sagitani, A., Kaneko, K., Mizutani, J., Nakamura, K., et al. (2006) Safety Evaluation of Excessive Intake of the Tablet Containing “Lactotripeptides (VPP, IPP)” in Subjects with Normal Blood Pressure to Mild Hypertension. Japanese Pharmacology & Therapeutics, 34, 1107-1117. (In Japanese)
Ishida, Y., Sagitani, A., Kaneko, K., Nakamura, Y., Mizutani, J. and Masuda, O. (2007) Antihypertensive Effects of the Tablet Containing “Lactotripeptide (VPP, IPP)” in Subjects with High Normal Blood Pressure to Mild Hypertension. Japanese Pharmacology & Therapeutics, 35, 1249-1260. (In Japanese)
Itakura, H., Ikemoto, S., Terada, S. and Kondo, K. (2001) The Effect of Sour Milk on Blood Pressure in Untreated Hypertensive and Normotensive Subjects. Journal of Japanese Society of Clinical Nutrition, 23, 26-31. (In Japanese)
Kajimoto, O., Aihara, K., Hirata, H., Takahashi, R. and Nakamura, Y. (2001) Safety Evaluation of Excessive Intake of the Tablet Containing “Lactotripeptides (VPP, IPP)” on Healthy Volunteers. Journal of Nutritional Food, 4, 37-46. (In Japanese)
Nakamura, Y., Kajimoto, O., Kaneko, K., Aihara, K., Mizutani, J., Ikeda, N., et al. (2004) Effects of the Liquid Yogurts Containing “Lactotripeptide (VPP, IPP)” on High-Normal Blood Pressure. Journal of Nutritional Food, 7, 123-137. (In Japanese)
Sano, J., Higuchi, T., Aihara, K., Mizuno, S., Kajimoto, O., Nakagawa, S., et al. (2004) Safety Evaluation of Excessive Intake of Drink Containing “Lactotripeptides (VPP, IPP)” in Subjects with Normal Blood Pressure to Mild Hypertension. Journal of Nutritional Food, 7, 17-30. (In Japanese)
Uchida, N., Ohsawa, K., Nakamura, T., Ohki, K., Amagai, S., Nakagawa, K., et al. (2016) Effect of Tablets Containing Lactotripeptides (VPP, IPP) on Vascular Endothelial Function in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial. Japanese Pharmacology & Therapeutics, 44, 1025-1034. (In Japanese)
Lawes, C.M., Rodgers, A., Bennett, D.A., Parag, V., Suh, I., Ueshima, H., et al. (2003) Blood Pressure and Cardiovascular Disease in the Asia Pacific Region. Journal of Hypertension, 21, 707-716. https://doi.org/10.1097/00004872-200304000-00013
Murakami, Y., Hozawa, A., Okamura, T. and Ueshima, H. (2008) Relation of Blood Pressure and All-Cause Mortality in 180,000 Japanese Participants: Pooled Analysis of 13 Cohort Studies. Hypertension, 51, 1483-1491. https://doi.org/10.1161/HYPERTENSIONAHA.107.102459
He, F.J. and MacGregor, G.A. (2004) Effect of Longer-Term Modest Salt Reduction on Blood Pressure. Cochrane Database of Systematic Reviews, CD004937. https://doi.org/10.1002/14651858.CD004937
Jurgens, G. and Graudal, N.A. (2003) Effects of Low Sodium Diet versus High Sodium Diet on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterols, and Triglyceride. Cochrane Database of Systematic Reviews, CD004022.
Messerli, F.H., Williams, B. and Ritz, E. (2007) Essential Hypertension. The Lancet, 370, 591-603. https://doi.org/10.1016/S0140-6736(07)61299-9